4-Chloro-2-[4-(methylaminomethyl)naphthalen-1-yl]oxybenzonitrile

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-Chloro-2-[4-(methylaminomethyl)naphthalen-1-yl]oxybenzonitrile
• 化学式: C₁₉H₁₅ClN₂O
• 分子量: 322.8
• InChiKey: FFDIYKZGKCUKOI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  45
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Novel compounds
  申请人：——

  公开号：US20040260088A1

  公开（公告）日：2004-12-23

  There are provided novel compounds of formula (I) wherein A, R 1 , R 3 , R 4 , R 5 , T, U, V, W, X and Y are as defined in the specification, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory diseases, pain and CNS diseases. 1

  提供了公式（I）的新化合物，其中A，R1，R3，R4，R5，T，U，V，W，X和Y如规范中所定义，并且它们的药物可接受盐; 以及它们的制备过程，包含它们的组合物和它们在治疗中的用途。这些化合物是一氧化氮合酶抑制剂，因此在治疗或预防炎症性疾病，疼痛和中枢神经系统疾病方面特别有用。
• Compounds for the inhibition of nitric oxide synthase
  申请人：Connolly Stephen

  公开号：US20060217424A1

  公开（公告）日：2006-09-28

  There are provided novel compounds of formula (I) wherein A, R 1 , R 3 , R 4 , R 5 , T, U, V, W, X and Y are as defined in the specification, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory diseases, pain and CNS diseases.

  提供了化学式(I)的新化合物，其中A、R1、R3、R4、R5、T、U、V、W、X和Y如规范中所定义，并且其药学上可接受的盐；以及它们的制备过程、含有它们的组合物以及它们在治疗中的用途。这些化合物是一氧化氮合酶的抑制剂，因此在治疗或预防炎症性疾病、疼痛和中枢神经系统疾病方面特别有用。
• NOVEL COMPOUNDS
  申请人：AstraZeneca AB

  公开号：EP1434756A1

  公开（公告）日：2004-07-07
• Selective Inhibitors Of i-NOS For Use Against Viral Infection
  申请人：UCL Business PLC

  公开号：US20180214430A1

  公开（公告）日：2018-08-02

  The present invention concerns compounds for use in the prevention of viral replication and/or the prevention or treatment of a viral infection, wherein the compounds are selective inhibitors of inducible nitric oxide synthase, and methods of preventing viral replication and/or preventing or treating viral infections in a subject comprising administering a prophylactically or therapeutically effective amount of the compounds.
• US7119122B2
  申请人：——

  公开号：US7119122B2

  公开（公告）日：2006-10-10